Arcus Biosciences RCUS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
Based on the most recent quarter.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's current ratio?
- Arcus Biosciences (RCUS) reported current ratio of 4× in Q1 2026.
- How has Arcus Biosciences's current ratio changed year-over-year?
- Arcus Biosciences's current ratio decreased by 24.8% year-over-year, from 5.4× to 4×.
- What is the long-term trend for Arcus Biosciences's current ratio?
- Over 5 years (2020 to 2025), Arcus Biosciences's current ratio has grown at a -6.3% compound annual growth rate (CAGR), from 6× to 4.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.